|1|Effort Testing in Schizophrenia and Schizoaffective Disorder: Validity Indicator Profile and Test of Memory Malingering Performance Characteristics. (24002172)
Hunt S.... Bascetta B.L.
|2|Differences between first episode schizophrenia and schizoaffective disorder. (23528796)
Cotton S.M.... Conus P.
|3|Anxiety disorder comorbidity in bipolar disorder, schizophrenia and schizoaffective disorder. (22906962)
Young S.... A9ngA1r D.
|4|Anhedonia of patients with schizophrenia and schizoaffective disorder is attributed to personality-related factors rather than to state-dependent clinical symptoms. (23518785)
|5|Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. (23846733)
Jarskog L.F.... Stroup T.S.
|6|Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study. (23938173)
Lohr J.B.... Ancoli-Israel S.
|7|Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis. (24026753)
Sarlon J.... Krasnianski A.
|8|Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice. (23244301)
Kulkarni J.... BERK M.
|9|Delayed response to repetitive transcranial magnetic stimulation treatment for intractable auditory hallucinations in schizoaffective disorder. (22563574)
Kelly D.... Galletly C.
|10|Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorder II. Predictive value of psychosocial factors. (21964946)
Ritsner M.S.... Ponizovsky A.M.
|11|Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder. (21784156)
Bychkov E.R.... Gurevich E.V.
|12|Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder. (21435142)
Hardy T.A.... Mudaliar S.
|13|Treatment adherence in schizophrenia and schizoaffective disorder. (21527119)
Goff D.C.... Freudenreich O.
|14|Impact of traumatic and violent victimization experiences in individuals with schizophrenia and schizoaffective disorder. (20921860)
Newman J.M.... Serper M.R.
|15|Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials. (21105275)
Hoffmann V.P.... Conley R.R.
|16|Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. (19238124)
de Oliveira I.R.... de Abreu P.B.
|17|Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease. (19300384)
Masopust J.... HosA!k L.
|18|Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate. (23051050)
Basu R.... Chengappa K.N.
|19|Consciously-perceived generalized epileptiform discharges in a man with schizoaffective disorder. (19751791)
Butler T.... Anthony D.T.
|20|Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan. (19426161)
Huang M.C.... Chen C.H.
|21|The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10. (19609099)
Cheniaux E.... Versiani M.
|22|A cross-sectional study of problem and pathological gambling in patients with schizophrenia/schizoaffective disorder. (19538900)
Desai R.A.... Potenza M.N.
|23|Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. (19497244)
Lindenmayer J.P.... Volavka J.
|24|Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder. (19689167)
Mace S.... Taylor D.
|25|Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. (18928413)
DelBello M.P.... Miceli J.
|26|Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005. (18031996)
Capasso R.M.... St Sauver J.
|27|Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable? (18031992)
Heinrichs R.W.... Miles A.A.
|28|Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder. (17517541)
|29|A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a danish population-based cohort. (18052560)
Laursen T.M.... Bo Mortensen P.
|30|A 24-month prospective outcome study of first-episode schizophrenia and schizoaffective disorder within an early psychosis intervention program. (17915975)
Sim K.... Siris S.G.
|31|fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk. (17719745)
Li X.... Delisi L.E.
|32|Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval. (17261186)
Gharabawi G.M.... Simpson G.M.
|33|microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. (17326821)
Perkins D.O.... Hammond S.M.
|34|Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder. (17729385)
Winter H.R.... Smith M.A.
|35|Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder. (16875781)
Gruber O.... Falkai P.
|36|An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives. (16530388)
Nunes S.O.... Itano E.N.
|37|Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. (16202177)
Risch S.C.... DeVane C.L.
|38|Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder. (19412470)
Basu R.... Brar J.S.
|39|Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. (16669719)
Kwon J.S.... Geun Oh C.
|40|Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder. (15933481)
Ciliberto N.... Lasser R.A.
|41|Aripiprazole and depression in schizoaffective disorder. (15741489)
Errico J.R.... Yates W.R.
|42|The profiling of ego defenses in clinical material to assess recovery from schizoaffective disorder. (14965856)
Ditto K.... Day M.
|43|Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder. (15352149)
Lasser R.A.... Davidson M.
|44|Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. (12363115)
Kane J.M.... Ali M.W.
|45|Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. (12223252)
Robinson D.G.... Lieberman J.A.
|46|CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders. (11591431)
Sharma R.P.... Bissette G.
|47|The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. (10067950)
Smith T.E.... Munich R.L.
|48|Intergenerational CAG repeat expansion at ERDA1 in a family with childhood-onset depression, schizoaffective disorder, and recurrent major depression. (10050972)
Vincent J.B.... Kennedy J.L.
|49|Schizoaffective disorder : consistency of diagnosis. (21430806)
Shrivastava A.... Rao S.
|50|An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder. (9690695)
Goff D.C.... Ko G.N.